Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Transfer Impedance in Cystic Fibrosis (Ztr)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2009 by Boston Children’s Hospital.
Recruitment status was  Recruiting
Information provided by:
Boston Children’s Hospital Identifier:
First received: August 27, 2008
Last updated: August 19, 2009
Last verified: August 2009
This study aims to determine whether respiratory system transfer impedance (Ztr) may fill an important clinical function by providing a reproducible, valid, and sensitive measure of airway obstruction in people with CF.

Cystic Fibrosis

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Transfer Impedance in Cystic Fibrosis (Ztr)

Resource links provided by NLM:

Further study details as provided by Boston Children’s Hospital:

Estimated Enrollment: 40
Study Start Date: August 2008

Ages Eligible for Study:   2 Years to 25 Years   (Child, Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Cystic Fibrosis Patients

Inclusion Criteria:

  • Between the ages of 2 to 25 Confirmed diagnosis of Cystic Fibrosis

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00743158

United States, Massachusetts
Childrens Hospital, Boston Recruiting
Boston, Massachusetts, United States, 02115
Contact: Lamia Momen, BA    617-355-6665   
Principal Investigator: Thomas R Martin, MD         
Sponsors and Collaborators
Boston Children’s Hospital
  More Information

Responsible Party: Thomas Martin, MD, Childrens Hospital, Boston Identifier: NCT00743158     History of Changes
Other Study ID Numbers: X08-01-0060 
Study First Received: August 27, 2008
Last Updated: August 19, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Boston Children’s Hospital:
transfer impedance
cystic fibrosis
pulmonary function test

Additional relevant MeSH terms:
Cystic Fibrosis
Pathologic Processes
Pancreatic Diseases
Digestive System Diseases
Lung Diseases
Respiratory Tract Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases processed this record on October 27, 2016